packageUramustine

uramustine

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Uramustine (uracil mustard) is an alkylating anticancer drug that has been used to treat cancers such as ovarian cancer, chronic leukemias, lymphosarcoma, mycosis fungoides, and polycythemia vera. It is listed as an approved antineoplastic agent, but it has no European Union marketing authorisation and its current availability is unclear.

Summary written by glm-5.3-flash from Wikidata Q15211075 and the WHO ATC classification; not checked by a person.

name:uramustine
ATC codes:L01AD08
DrugBank:DB00791
PubChem CID:6194
ChEBI:9884
Wikidata:Q15211075
formula:C8H11Cl2N3O2
molar mass:252.095 g/mol (PubChem CID 6194)
logP:0.5 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown